PRESS RELEASE
For Immediate Release
July 2020
McLean, VA – The American Academy of Clinical Toxicology has announced a new strategic plan and revised mission statement.
AACT’s new mission statement is to champion the advancement of treatment, research, education, and prevention of poisoning injury caused by chemicals, drugs, and toxins. The Strategic Plan outlines the Academy’s four priorities that will enable the organization to achieve its mission within the next five years including uniting members to optimize patient care, educating clinicians in clinical toxicology, fostering innovative research and acquiring the necessary resources, infrastructure and members to ensure the long-term financial sustainability of the organization.
Dr. Christopher Hoyte lead the efforts and has worked with the Board of Directors to establish internal champions for the sub-objectives. The sub-objectives are viewed as projects that will contribute to the advancement of the priorities including but not limited to elevating the status and recognition of the AACT Fellows Program, providing members support for board exams, expanding research funding, establishing mentorship programs, increasing educational opportunities for members and establishing strategies to increase financial sustainability.
The AACT Board of Directors welcomes comments about the plan. Specific feedback should be sent to admin@clintox.org.